Gault Laura 4
4 · Sage Therapeutics, Inc. · Filed Nov 1, 2022
Insider Transaction Report
Form 4
Gault Laura
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-11-01+64,410→ 64,410 totalExercise: $37.88Exp: 2032-11-01→ Common Stock (64,410 underlying)
Footnotes (1)
- [F1]The securities awarded on November 1, 2022 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 16,102 shares of common stock shall vest on the one year anniversary of October 31, 2022, with 48,308 shares vesting in 36 equal monthly installments thereafter.